Other aws Support

Other support for Life Science start-ups

With the aws Venture Capital Initiative we want to stimulate the financing of research- and technology-oriented start-ups and win international venture capital funds for an increased engagement in Austria. Investments in VC funds, which have a focus on investments in technology-oriented Austrian start-ups - at market conditions.

https://www.aws.at/aws-venture-capital-initiative/

 

With aws Business Angel Fund, we help start-ups to take off by doubling the equity holdings of business angels through co-investments.

https://www.aws.at/aws-business-angel-fonds/

 

With aws protecting innovation, we support you in developing your individual, business-specific intellectual property strategy, i.e. we help identify, secure, protect, and exploit your intellectual property.

https://www.aws.at/en/aws-protecting-innovation/

 

 

Wings4innovation GmbH

wings4innovation GmbH (w4i) was founded as affiliate of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), a new European financing vehicle for early-stage drug discovery projects with focus in Austria and Germany to facilitate translation of promising results from Austrian basic research organisations in life sciences into professional drug discovery projects and their commercialisation w4i has access to funds of KHAN-I and is open to all research organisations in Austria.

More information at: https://www.w4i.org/index.html

 

News

Icon LISA News = LISA News
12.12.2024
Pharmig: Woran heute für morgen geforscht wird
12.12.2024
Österreichischer Verband der Impfstoffhersteller (ÖVIH): Die europäische Impfstoffpipeline bleibt gut gefüllt
12.12.2024
Ignaz Semmelweis Institut nimmt seine Arbeit auf
11.12.2024
Karl Landsteiner Privatuniversität: Ionentherapie großer Tumore optimiert
11.12.2024
CEBINA and Danube BioVentures announce the launch of TAG Therapeutics developing a cutting-edge precision medicine for telomere pathologies and age-related disorders